During the past decade, Las Vegas Cancer Center-Medical Center conducted 121 clinical trials. In the 10-year time frame, 121 clinical trials started and 59 clinical trials were completed, i.e. on average, 48.8% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 49 clinical trials were completed. i.e. 122.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Las Vegas Cancer Center-Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 76 trials, followed by "SWOG Cancer Research Network" with 33 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "CTI BioPharma" with 12 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Las Vegas Cancer Center-Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 79 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Las Vegas Cancer Center-Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials) and "Stage IV Cutaneous Melanoma AJCC v6 and v7" (6 trials). Many other conditions were trialed in "Las Vegas Cancer Center-Medical Center" in a lesser frequency.

Most popular intervention types in "Las Vegas Cancer Center-Medical Center" are "Drug" (129 trials), "Other" (103 trials), "Biological" (66 trials), "Procedure" (41 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (50 trials), "Quality-of-Life Assessment" (39 trials), "Computed Tomography" (25 trials), "Biospecimen Collection" (24 trials) and "Nivolumab" (21 trials). Other intervention names were less common.

The vast majority of trials in "Las Vegas Cancer Center-Medical Center" are 138 trials for "All" genders, 19 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Las Vegas Cancer Center-Medical Center". undefined are not yet recruiting, 42 are recruiting, 77 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Las Vegas Cancer Center-Medical Center, 4 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Las Vegas Cancer Center-Medical Center, 3 "Phase 1" clinical trials were conducted, 80 "Phase 2" clinical trials and 81 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".